Comparison of Patient-Specific Quality Assurance of 6 MV and 10 MV VMAT plan at Isocenter using Improved Gamma Evaluation Algorithm

Document Type : Original Paper




3 Dean, Faculty of Science Invertis University Bareilly-243 123 (U.P.) India


Introduction: To compare Patient-Specific Quality Assurance (PSQA) of 6 MV and 10 MV Volume Modulated Arc Therapy (VMAT) plans performed with Electronic Portal Imaging Device (EPID) kept at Isocenter 100 cm (Source to Imager Distance (SID)) using an Improved Gamma Evaluation algorithm. Material and Methods: Previously treated patients with 6 MV IMRT for Pelvic cancers were planned, on Eclipse TPS, with 6 MV and 10 MV photon beams using VMAT technology. The PSQA was performed using EPID and investigated the effect on Area Gamma, Maximum Gamma & Average Gamma.
Results: The mean Area Gamma passing rate (%GP±Standard Deviation(σ)) for 6 MV was 97.06±3.70, 95.42±5.31, 90.93±7.29, 86.55±9.10 and for 10 MV  97.14±6.08, 95.8±8.47, 94.62±9.45, 91.97±13.50 using the criteria 3%/3 mm, 3%/2 mm, 2%/3 mm, 2%/2 mm respectively.  Similarly, for mean Maximum Gamma value for 6 MV was 2.50±0.89, 2.72±0.94, 3.32±1.13, 3.56±1.02 and for 10 MV 2.17±0.62, 2.42±0.72, 2.84±0.90, 3.26±0.94 respectively. For mean average gamma, value for 6 MV was 0.36±0.09, 0.42±0.10, 0.45±0.12, 0.53±0.13 and for 10 MV was 0.27±0.16, 0.32±0.19, 0.34±0.20, 0.41±0.24.
Conclusion: There is a marked difference between Area Gamma Passing Rate of 6 MV and 10 MV photon beam. The gamma criteria of 3%/2 mm with a 5% Threshold limit and 95% Area Gamma Passing Rate can be used for PSQA using EPID at Isocenter for 6 MV and 10 MV photon beam. There is no marked significant difference in values of mean Maximum Gamma and mean Average Gamma for 6 MV and 10 MV photon beams PSQA


Main Subjects

  1. Dogan N. Tools for IMRT QA. Department Of Radiation Oncology, Virginia Commonwealth University, Medical College Of Virginia Hospitals, Richmond, VA, USA. 2005 Jun 1.
  2. Miften M, Olch A, Mihailidis D, Moran J, Pawlicki T, Molineu A, and et al. Tolerance limits and methodologies for IMRT measurement‐based verification QA: recommendations of AAPM Task Group No. 218. Medical physics. 2018 Apr;45(4):e53-83.
  3. Stralingsdosimetrie NC, Commissie N, Stralingsdosimetrie V, Stralingsdosimetrie NC. Code of practice for the quality assurance and control for intensity modulated radiotherapy. no. June. 2013 Jun.
  4. Stralingsdosimetrie NC. Code of Practice for the Quality Assurance and Control for Volumetric Modulated Arc Therapy. Report. 2015 Feb;24:9-59.
  5. Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, and et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Medical physics. 2003 Aug;30(8):2089-115.
  6. Son J, Baek T, Lee B, Shin D, Park SY, Park J, and et al. A comparison of the quality assurance of four dosimetric tools for intensity modulated radiation therapy. Radiology and oncology. 2015 Sep;49(3):307.
  7. Sharma DS, Mhatre V, Heigrujam M, Talapatra K, Mallik S. Portal dosimetry for pretreatment verification of IMRT plan: a comparison with 2D ion chamber array. Journal of applied clinical medical physics. 2010 Sep;11(4):238-48.
  8. Merheb C, Chevillard C, Ksouri W, Fawzi M, Bollet M, Toledano A. Comparison between two different algorithms used for pretreatment QA via aSi portal images. Journal of applied clinical medical physics. 2015 May;16(3):141-53.
  9. Winkler P, Hefner A, Georg D. Dose‐response characteristics of an amorphous silicon EPID. Medical physics. 2005 Oct;32(10):3095-105.
  10. Spezi E, Lewis DG. Gamma histograms for radiotherapy plan evaluation. Radiotherapy and oncology. 2006 May 1;79(2):224-30.
  11. Antonuk LE. Electronic portal imaging devices: a review and historical perspective of contemporary technologies and research. Physics in Medicine & Biology. 2002 Mar 1;47(6):R31.
  12. Depuydt T, Van Esch A, Huyskens DP. A quantitative evaluation of IMRT dose distributions: refinement and clinical assessment of the gamma evaluation. Radiotherapy and oncology. 2002 Mar 1;62(3):309-19.
  13. Létourneau D, Gulam M, Yan D, Oldham M, Wong JW. Evaluation of a 2D diode array for IMRT quality assurance. Radiotherapy and oncology. 2004 Feb 1;70(2):199-206.
  14. Greer PB, Popescu CC. Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy. Medical physics. 2003 Jul;30(7):1618-27.
  15. Van Esch A, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields. Radiotherapy and oncology. 2004 May 1;71(2):223-34.
  16. Krishna Murthy K, Anandagiribabu A, Prasad PB, Kaviarasu K. Patient-specific quality assurance of RapidArc treatments: Portal prediction dosimetry compared with phantom studies. Biomed Imaging Interv J. 2012 Oct 1;8:e28-34.
  17. Fogliata A, Clivio A, Fenoglietto P, Hrbacek J, Kloeck S, Lattuada P, and et al. Quality assurance of RapidArc in clinical practice using portal dosimetry. The British journal of radiology. 2011 Jun;84(1002):534-45.
  18. Wagner D, Vorwerk H. Two years experience with quality assurance protocol for patient related Rapid Arc treatment plan verification using a two dimensional ionization chamber array. Radiation oncology. 2011 Dec;6(1):1-8.
  19. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Medical physics. 1998 May;25(5):656-61.
  20. Low DA, Dempsey JF. Evaluation of the gamma dose distribution comparison method. Medical physics. 2003 Sep;30(9):2455-64.
  21. Low DA. Gamma dose distribution evaluation tool. InJournal of Physics: Conference Series 2010 Nov 1 (Vol. 250, No. 1, p. 012071). IOP Publishing.
  22. van Zijtveld M, Dirkx ML, de Boer HC, Heijmen BJ. Dosimetric pre-treatment verification of IMRT using an EPID; clinical experience. Radiotherapy and oncology. 2006 Nov 1;81(2):168-75.
  23. Roxby KJ, Crosbie JC. Pre-treatment verification of intensity modulated radiation therapy plans using a commercial electronic portal dosimetry system. Australasian physical & engineering sciences in medicine. 2010 Mar;33(1):51-7.
  24. Matsumoto K, Okumura M, Asai Y, Shimomura K, Tamura M, Nishimura Y. Dosimetric properties and clinical application of an a-Si EPID for dynamic IMRT quality assurance. Radiological physics and technology. 2013 Jan;6(1):210-8.
  25. Jayesh K, Ganesh T, Suganthi D, Mohan R, Rakesh CJ, Sarojkumar DM, Jacob SJ. Dosimetric comparison of aSi1000 EPID and ImatriXX 2-D array system for volumetric modulated arc and intensity modulated radiotherapy patient specific quality assurance. Int J Math Comput Phys Electrical Comput Eng. 2013 Mar 27;7(3):393-4.
  26. Surendran S, Rao DP, Cyriac SL. Study of feasibility of portal dosimetry in comparison with ImatriXX 2-D array system for IMRT and Rapid arc patient specific QA. IOSR-JEN. 2014;4(6):11-15.
  27. Mohamed IE, Ibrahim AG, Zidan HM, El-Bahkiry HS, El-sahragti AY. Physical dosimetry of volumetric modulated arc therapy (VMAT) using EPID and 2D array for quality assurance. The Egyptian Journal of Radiology and Nuclear Medicine. 2018 Jun 1;49(2):477-84.
  28. More M, Jain V, Gurjar OP. Clinical Experience of Intensity Modulated Radiotherapy Pre-Treatment Quality Assurance for Carcinoma Head and Neck Patients with EPID and IMatriXX in Rural Center. Journal of Biomedical Physics & Engineering. 2020 Dec;10(6):691.
  29. More M, Jain V, Gurjar OP. Pre-treatment Verification Performed with Electronic Portal Imager Device (EPID) and IMatriXX for 204 Cancer Patients Treated with Intensity Modulated Radiotherapy (IMRT) –Phantom Based Study. Iran J Med Phys . 2021; 18: 444-451.



Volume 19, Issue 5
September and October 2022
Pages 282-289
  • Receive Date: 06 August 2021
  • Revise Date: 11 February 2022
  • Accept Date: 14 February 2022
  • First Publish Date: 14 February 2022